NSAIDs Modulate Clonal Evolution in Barrett's Esophagus

Cancer is considered an outcome of decades-long clonal evolution fueled by acquisition of somatic genomic abnormalities (SGAs). Non-steroidal anti-inflammatory drugs (NSAIDs) have been shown to reduce cancer risk, including risk of progression from Barrett's esophagus (BE) to esophageal adenoca...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Kostadinov, Rumen L., Kuhner, Mary K., Li, Xiaohong, Sanchez, Carissa A., Galipeau, Patricia C., Paulson, Thomas G., Sather, Cassandra L., Srivastava, Amitabh, Odze, Robert D., Blount, Patricia L., Vaughan, Thomas L., Reid, Brian J., Maley, Carlo C.
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2013
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3681672/
https://ncbi.nlm.nih.gov/pubmed/23785299
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pgen.1003553
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares